Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, an... Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.84 | -10.5131414268 | 7.99 | 8.22 | 6.955 | 1227118 | 7.36640339 | CS |
| 4 | -2.43 | -25.3653444676 | 9.58 | 10.01 | 6.955 | 1155037 | 8.36472154 | CS |
| 12 | -0.215 | -2.91921249151 | 7.365 | 14.43 | 6.955 | 2107010 | 10.43429316 | CS |
| 26 | -0.94 | -11.6192830655 | 8.09 | 14.43 | 6.56 | 1597627 | 9.45248024 | CS |
| 52 | -3.66 | -33.8575393154 | 10.81 | 14.43 | 6.56 | 1277952 | 9.47819152 | CS |
| 156 | -15.04 | -67.7782785038 | 22.19 | 31.78 | 6.56 | 1204953 | 15.83349538 | CS |
| 260 | -32.65 | -82.0351758794 | 39.8 | 141.01 | 6.56 | 1219270 | 26.69388926 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
